|
|
|
|
|
|
Atyr Pharma Inc (LIFE)
|
|
3.725 +0.050 (+1.361%)
|
6/22/2017 12:04pm
|
|
Open:
|
3.700
|
Pre. Close:
|
3.675
|
|
High:
|
3.750
|
Low:
|
3.550
|
|
Volume:
|
16,561
|
Market Cap:
|
88.68M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
3.86 - 3.89
|
3.89 - 3.95
|
|
Low:
|
3.39 - 3.41
|
3.41 - 3.44
|
|
Close:
|
3.57 - 3.68
|
3.68 - 3.87
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-21 4:33:38 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 4.32  One year: 5.05
|
|
Support:
|
Support1: 3.36 Support2: 3.15
|
|
Resistance:
|
Resistance1:
3.70 Resistance2: 4.32
|
|
Pivot:
|
3.44
|
|
Moving Averages:
|
MA(5): 3.55 MA(20): 3.45
MA(100): 3.38 MA(250): 3.13
|
|
MACD:
|
MACD(12,26):
0.07 Signal(12,26,9): 0.05
|
|
%K %D:
|
%K(14,3): 98.48 %D(3): 90.85
|
|
RSI:
|
RSI(14): 63.46
|
|
52-Week:
|
High: 4.450
Low: 2.100 Change(%): 32.2
|
|
Average Vol(K):
|
3-Month: 1496
10-Days 19
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.LIFE has closed below upper band by 3.1%. Bollinger Bands are 18.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Thu, 16 Mar 2017 20:08:24 GMT
aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results
Mon, 03 Apr 2017 12:00:00 GMT
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
Wed, 10 Aug 2016 20:06:59 GMT
aTyr Pharma Announces Second Quarter 2016 Operating Results
Thu, 07 May 2015 01:30:00 GMT
San Diego's aTyr Pharma Raises Total Proceeds of $75M in IPO
Wed, 30 Mar 2016 20:01:58 GMT
aTyr Pharma Appoints Sanjay Shukla, MD, MS, as Chief Medical Officer
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
